BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted seven newly-hired employees stock options to purchase an aggregate of 38,600 shares, and restricted stock units covering an aggregate of 26,450 shares, of BioCryst common stock.
August 4, 2023
· 1 min read